Back to AZN Stock Lookup

AstraZeneca (AZN) –

Aug 22, 2016 06:09 AM Eli Lilly & Co. (LLY), AstraZeneca (AZN) Receive FDA Fast Track Designation for AZD3293 as BACE Inhibitor
Aug 18, 2016 08:53 AM Form 6-K ASTRAZENECA PLC For: Aug 18
Aug 16, 2016 07:45 AM Form 6-K ASTRAZENECA PLC For: Aug 16
Aug 16, 2016 07:10 AM Adherium, AstraZeneca (AZN) Enter Smartinhaler Platform Supply Agreement
Aug 10, 2016 12:38 PM Form 6-K ASTRAZENECA PLC For: Aug 10
Aug 10, 2016 09:45 AM AstraZeneca (AZN) Announces Positive Data from Two SYMBICORT Studies; Primary Endpoints Met
Aug 9, 2016 06:28 AM Form 6-K ASTRAZENECA PLC For: Aug 09
Aug 9, 2016 05:49 AM AstraZeneca (AZN) Reports Selumetinib Phase 3 Missed Primary Endpoint in NSCLC (ARRY)
Aug 9, 2016 02:01 AM AstraZeneca Provides Update On Phase III Trial Of Selumetinib In Non-Small Cell Lung Cancer
Aug 5, 2016 03:18 PM Notable 52-Week Highs and Lows 8/5: (MRK) (MTZ) (AZN) High; (CPSI) (BBRG) (APRI) Low
Aug 5, 2016 10:43 AM AstraZeneca hits 2014 Pfizer bid price, helped by Bristol's woes
Aug 5, 2016 08:24 AM Merck (MRK) Surges After Bristol-Myers Squibb's (BMY) CheckMate -026 Trial Fails
Aug 1, 2016 11:58 AM Form 6-K ASTRAZENECA PLC For: Aug 01
Aug 1, 2016 11:41 AM Form 6-K ASTRAZENECA PLC For: Aug 01
Jul 28, 2016 02:52 PM AstraZeneca (AZN) August calls active after declined comment on takeover speculation, report
Jul 28, 2016 12:29 PM Form 6-K ASTRAZENECA PLC For: Jul 28
Jul 28, 2016 08:13 AM AstraZeneca (AZN) Tops Q2 EPS by 7c
Jul 28, 2016 06:42 AM AstraZeneca (AZN) sees $40 - $41 billion in sales by 2023 - Bloomberg, citing CEO Soriot
Jul 27, 2016 07:51 AM Form 6-K ASTRAZENECA PLC For: Jul 27
Jul 20, 2016 11:05 AM Mylan (MYL) Announces U.S. Launch of Generic Crestor
Jul 19, 2016 04:29 PM Valeant Pharma (VRX) Announces FDA AdCom Recommendation of Brodalumab as Plaque Psoriasis Treatment
Jul 19, 2016 04:27 PM FDA Advisory Committee Recommends Approval Of Brodalumab For Treatment Of Moderate-To-Severe Plaque Psoriasis
Jul 19, 2016 01:01 PM Form 6-K ASTRAZENECA PLC For: Jul 19
Jul 18, 2016 07:51 AM Form 6-K ASTRAZENECA PLC For: Jul 18
Jul 18, 2016 07:13 AM AstraZeneca (AZN) Announces AURA3 Phase III Met Primary Endpoint in 2nd-Line Lung Cancer Trial
Jul 18, 2016 07:12 AM TAGRISSO® (OSIMERTINIB) Met Primary Endpoint in Phase III 2nd-Line Lung Cancer Trial
Jul 12, 2016 07:42 AM Argus Starts AstraZeneca (AZN) at Hold
Jul 5, 2016 08:25 AM Pfizer's (PFE) 'Stalking Horse Bid' Leaves Little Room for BIND Therapeutics' (BIND) Holders -Stifel
Jul 1, 2016 12:43 PM Form 6-K ASTRAZENECA PLC For: Jul 01
Jul 1, 2016 06:18 AM Form 6-K ASTRAZENECA PLC For: Jul 01
Jul 1, 2016 06:11 AM AstraZeneca (AZN) Terminates Valeant's (VRX) Brodalumab Development Agreement for Europe
Jul 1, 2016 02:00 AM Valeant Pharmaceuticals Announces New Licensing Arrangement For Brodalumab In Europe
Jun 29, 2016 03:49 PM TESARO (TSRO) Niraparib Data Suggests PARP Inhibitors Will be Important - Stifel (CLVS) (AZN)
Jun 29, 2016 07:56 AM Credit Suisse Sees $157B of FCF Through 2019 Available for M&A in Biotech/Pharma Sector
Jun 28, 2016 07:12 AM Form 6-K ASTRAZENECA PLC For: Jun 28
Jun 23, 2016 10:56 AM Antares Pharma (ATRS) Announces Teva (TEVA) Settles Patent Litigation with AstraZeneca (AZN)
Jun 23, 2016 08:32 AM Teva Pharma (TEVA) Enters Patent Settlement Agreement with AstraZeneca
Jun 23, 2016 06:33 AM AstraZeneca (AZN) Receives CDC ACIP Interim Recomendation for FluMist Quadrivalent in U.S. Market
Jun 23, 2016 06:27 AM Form 6-K ASTRAZENECA PLC For: Jun 23
Jun 21, 2016 10:00 AM Roger Ulrich Joins Board of Remedy Pharmaceuticals
Jun 14, 2016 10:09 AM Form 6-K ASTRAZENECA PLC For: Jun 14
Jun 14, 2016 08:00 AM AstraZeneca Introduces AZhelps, an Innovative Savings and Support Program to Help Patients with Their Medicines
Jun 11, 2016 11:00 AM AstraZeneca Presents New Data from Multiple Studies on the Effect of BYDUREON on Glucose Fluctuations in Patients with Type 2 Diabetes
Jun 11, 2016 11:00 AM AstraZeneca Presents Findings from Two Pooled Analyses at the 76th Scientific Sessions of the American Diabetes Association Evaluating Dapagliflozin in Type 2 Diabetes Patients with Renal Impairment a
Jun 9, 2016 05:42 PM Valeant Pharma (VRX) Announces Brodalumab FDA Advisory Committee Meeting On July 19
Jun 9, 2016 05:40 PM Valeant To Participate In FDA Advisory Committee Meeting On July 19
Jun 9, 2016 06:48 AM Form 6-K ASTRAZENECA PLC For: Jun 09
Jun 8, 2016 08:00 AM AstraZeneca to Highlight Scientific Advancements Across Its Diabetes Portfolio at the American Diabetes Association 76th Scientific Sessions
Jun 7, 2016 10:11 AM Relypsa's (RLYP) Rating Moves Back to 'Underweight' at Morgan Stanley; Form 483 Hints at Near-Term Competition, Says Analyst
Jun 6, 2016 12:38 PM Tagrisso (Osimertinib) Shows Clinical Activity in Patients with Leptomeningeal Disease from Lung Cancer

Back to AZN Stock Lookup